SCHEMBL6444614

SCHEMBL6444614

O=C(NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)c1cccnc1)c1cccnc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 1/20 0.67
LMNA P02545 1/20 0.60
CTRC Q99895 1/20 0.59
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
CYP3A4 P08684 1/20 0.56
KMT2A Q03164 2/20 0.56
RAB9A P51151 2/20 0.56
MEN1 O00255 1/20 0.56
NPC1 O15118 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
EPHX2 P34913 2/20 0.53
KDM4E B2RXH2 1/20 0.50
PLOD2 O00469 1/20 0.50
GAA P10253 1/20 0.50
GPR132 Q9UNW8 4/20 0.49
CMKLR2 P46091 1/20 0.49
CMKLR1 Q99788 1/20 0.49
THRB P10828 1/20 0.49
HDAC1 Q13547 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6452567 0.87 CA2 (0.56) ECE1LMNACTRCCYP2C9CYP2C19
SCHEMBL1817969 0.86 ECE1 (0.70) ECE1LMNACTRCCYP2C9CYP2C19
SCHEMBL6931878 0.85 CTRB1 (0.59) RAB9ANPC1
SCHEMBL6446529 0.85 LMNA (0.56) ECE1LMNACTRCCYP2C9CYP2C19
SCHEMBL6448868 0.85 ROCK2 (0.56) ECE1CYP2C19CYP3A4RAB9AEPHX2
SCHEMBL3497405 0.82 GPR132 (0.69) ECE1LMNACTRCCYP2C9CYP2C19
SCHEMBL30037998 0.82 GPR132 (0.69) ECE1LMNACTRCCYP2C9CYP2C19
SCHEMBL3078645 0.82 LMNA (0.76) ECE1LMNACTRCCYP2C9CYP2C19
SCHEMBL2229201 0.82 GPR132 (0.69) ECE1LMNACTRCCYP2C9CYP2C19
Nicofetamide SCHEMBL254029 0.81 ECE1 (0.67) ECE1LMNACTRCCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed